Closing in 2 seconds...
Please click on the company name in order to view the full session program
SESSION 1: EARLY DETECTION AND EARLY INTERVENTION OF ALZHEIMER'S DISEASE
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Janssen Pharmaceutical K.K.
Sunday, September 17, 12:55-14:40, Room A [Language: English]
Chair: Takeshi Ikeuchi (Japan), Kenji Nakashima (Japan)
The Earlier, The Better. Japanese Medical and Social System for Early Detection and Early Intervention of Patients with Alzheimer's Disease
Hisatomo Kowa, Japan
The benefits and challenges of early diagnosis of dementia
Takeshi Ikeuchi, Japan
***************
SESSION 2: CUTTING EDGE OF NEW TREATMENT ON PARKINSON'S DISEASE
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Sumitomo Dainippon Pharma
Sunday, September 17, 12:55-14:40, Annex Hall 2 [Language: Japanese translated to English]
Chair: Masahiro Nomoto, Japan
From Oxidative Stress and Environmental Toxins to Prion-Like Propagation of a-Synuclein; A Newly Proposed Pathogenesis of Parkinson's Disease
Makio Takahashi, Japan
Reduced cardiac MIBG Uptake Can be a Potential Biomarker for The Presence of Lewy Bodies
Satoshi Orimo, Japan
Drug Therapy from Japan to The World
Miho Murata, Japan
Panel Discussion: Considering Long-term Prognosis of Patients
SESSION 3: CUTTING EDGE: BIOMARKER OF DISEASE ACTIVITY IN MS
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Novartis Pharma K.K.
Sunday, September 17, 12:55-13:45, Room D [Language: English]
Chair Jun-ichi Kira, Japan
Imaging Biomarkers Focusing on q-space Myelin Map
Jin Nakahara, Japan
Molecular Biomarkers Focusing on Neurofilament Light Chain
Jens Kuhle, Switzerland
SESSION 4:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Alexion
Sunday, September 17, 12:55-13:45, Room E [Language: Japanese translated to English]
Chair: Akio Suzumura, Japan
Overview of Complement System and Its Role of Pathogenesis In Myasthenia Gravis
Taroh Kinoshita, Japan
Current Status and Issues of Myasthenia Gravis Treatment
Kimiaki Utsugisawa, Japan
SESSION 5:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Medtronic
Sunday, September 17, 12:55-13:45, Room B-1 [Language: Japanese]
Chair: Kenichi Fujimoto, Japan
DBS in Movement Disorder from My Experience as a Referral Physician
Kazuto Yoshida, Japan
Experience of Implementing DBS Therapy into My Practice
Ichiro Yabe, Japan
Panel Discussion
SESSION 6:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eisai Co., Ltd.
Sunday, September 17, 12:55-13:45, Room B-2 [Language: English]
Chair: Kazutaka Jin, Japan
Epilepsy and Sleep
Manuel Toledo, Spain
**************
SESSION 7:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Mylan EPD
Sunday, September 17, 13:50-14:40, Room D [Language: Japanese]
Chair: Masaaki Hirayama, Japan
Up to Date the Management of Chronic Constipation- How to treat constipation of Parkinson's Disease Patients
Atsushi Nakajima, Japan
SESSION 8:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY GlaxoSmithKline
Sunday, September 17, 13:50-14:40, Room E [Language: English]
Chair: Hiroshi Shibasaki, Japan
Regaining Active Function after Stroke: Botulinum Toxin Therapy with Rehabilitation
Ryuji Kaji, Japan
SESSION 9:
Sunday, September 17, 13:50-14:40, Room B-1 [Language: Japanese]
Chair: Akio Ikeda, Japan
Clinical Condition and Medical Cooperation in Tuberous Sclerosis
Takehiro Ueda, Japan
SESSION 10:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Otsuka Pharmaceutical Co., Ltd. / UCB Japan
Sunday, September 17, 13:50-14:40, Room B-2 [Language: Japanese]
Chair: Shozo Tobimatsu, Japan
Revised Points of Epilepsy Guideline 2017 of Japanese Society of Neurology
Naoki Akamatsu, Japan
SESSION 11:
Monday, September 18, 12:55-13:45, Annex Hall 2 [Language: English]
Chair: Nobutaka Hattori, Japan
Current Strategy for Management of PD Patients with Medication
Atsushi Takeda, Japan
SESSION 12:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Eli Lilly
Monday, September 18, 12:55-13:45, Room D [Language: Japanese]
Chair: Yasuomi Ouchi, Japan
Pathological and Molecular Heterogeneity of "Clinically Probable Alzheimer's Disease"
Masahito Yamada, Japan
SESSION 13:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Mitsubishi Tanabe Pharma Corporation
Monday, September 18, 12:55-13:45, Room E [Language: English]
Chair: Kazutoshi Nishiyama, Japan
Brain Atrophy and Cognitive Impairment in Multiple Sclerosis
Ichiro Nakashima, Japan
SESSION 14:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Pfizer Japan Inc.
Monday, September 18, 12:55-13:45, Swan Hall [Language: English translated to Japanese]
Chair: Yukio Ando, Japan
Current Topics in Amyloidosis from Alzheimer Disease to ATTR Amyloidosis
Yoshiki Sekijima (Japan)
Diagnosis and Therapy of Hereditary ATTR Amyloidosis
Taro Yamashita (Japan)
SESSION 15:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Daiichi-Sankyo
Monday, September 18, 12:55-13:45, Room B-1 [Language: Japanese]
Chair: Shun Shimohama, Japan
Neurodegenerative Diseases as Oligomeropathy
Kenjiro Ono, Japan
SESSION 16:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nihon Medi-Physics Co., Ltd.
Monday, September 18, 12:55-13:45, Room B-2 [Language: English]
Chair: Ryosuke Takahashi, Japan
Construction of Japanese Normal Database for Dopamine Transporter SPECT
Hiroshi Matsuda, Japan
SESSION 17:
Monday, September 18, 13:50-14:40, Annex Hall 2 [Language: English]
Chair: Naoki Akamatu, Japan
Current Trends in Epilepsy Diagnosis and Treatment
Kazutaka Jin, Japan
SESSION 18:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Bayer Yakuhin, Ltd
Monday, September 18, 13:50-14:40, Room D [Language: Japanese translated to English]
Chair: Shinichiro Uchiyama, Japan
Management of Acute Stroke Patients with NVAF - Optimal Timing to Start DOAC -
Masahiro Yasaka, Japan
SESSION 19: NEW STANDARD OF CARE FOR CRYPTOGENIC STROKE AND ATRIAL FIBRILLATION
Monday, September 18, 13:50-14:40, Room E [Language: English]
Chair: Yoichiro Hashimoto, Japan
The Latest Update on Reveal LINQ Monitoring - Building Cryptogenic Stroke Pathways
Robert N. Sawyer, Jr., U.S.
ICM for Cryptogenic Stroke Patients in Japan
Kazunori Toyoda, Japan
SESSION 20:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Pfizer Japan Inc./Eisai Co., Ltd.
Monday, September 18, 13:50-14:40, Swan Hall [Language: Japanese translated to English]
Chair: Masahiro Sonoo, Japan
Diagnosis and Treatment of Pain in Neuropathy
Yoshiyuki Mitsui, Japan
SESSION 21:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY ONO PHARMACEUTICAL CO., LTD.
Monday, September 18, 13:50-14:40, Room B-1 [Language: English]
Chair: Mikio Shoji, Japan
Current Status and Perspectives of Dementia Treatment: A Possibility of BuChE Inhibitor Against Alzheimer's Disease
SESSION 22:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY InSightec Japan
Monday, September 18, 13:50-14:40, Room B-2 [Language: Japanese]
Chair: Ritsuko Hanajima, Japan
Treatment of Essential Tremor with Focus Ultrasound
Hideki Mochizuki, Japan
SESSION 23:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Takeda Pharmaceutical
Tuesday, September 19, 12:55-13:45, Annex Hall 2 [Language: Japanese translated to English]
Chair: Hideki Mochizuki, Japan
Diagnosis of Parkinson's Disease: Past, Present and Future
Kazushi Takahashi, Japan
SESSION 24:
Tuesday, September 19, 12:55-14:40, Room D [Language: English]
Chair: Gen Sobue (Japan), Satoshi Kaneko (Japan)
Perspective of ALS Therapy from New Molecular Mechanism
Osamu Onodera, Japan
Gene Therapy Against Spinocerebellar Ataxia
Hitoshi Okazawa, Japan
SESSION 25:
Tuesday, September 19, 12:55-13:45, Room E [Language: Japanese]
Chair: Yasuo Terayama, Japan
Management for Intractable or Puzzling Headaches - How to Diagnose and How to Treat
Shinya Manaka, Japan
SESSION 26: ANTICOAGULATION
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Bristol-Myers Squibb / Pfizer Japan Inc.
Tuesday, September 19, 12:55-13:45, Swan Hall [Language: Japanese translated to English]
Chair: Norihiro Suzuki, Japan
Mechanisms of Thrombus Formation
Yujiro Asada, Japan
Anticoagulant Therapy for Stroke – Focus on Important Deep Vein Thrombosis in Clinical Field
Hidetaka Mitsumura, Japan
SESSION 27:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nihon Pharmaceutical Co.,LTD.
Tuesday, September 19, 12:55-13:45, Room B-1 [Language: English]
Chair: Ryuji Kaji, Japan
CIDP: Update 2017, and Maintenance IVIg Treatment
Satoshi Kuwabara, Japan
SESSION 28:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Daiichi-Sankyo / UCB Japan
Tuesday, September 19, 12:55-13:45, Room B-2 [Language: Japanese]
Chair: Sadatoshi Tsuji, Japan
Ictal Semiology for Accurate Diagnosis of Epilepsy
Riki Matsumoto, Japan
SESSION 29:
Tuesday, September 19, 12:55-13:45, Room H [Language: Japanese]
Chair: Hiroyuki Arai, Japan
Making an Accurate Diagnosis with Experts: A Hands-On Seminar for Clinical, Imaging and Pathological Diagnosis on Dementia
Kenji Ishii (Japan), Hiroshi Matsuda (Japan), Shigeo Murayama (Japan)
SESSION 30:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Kyowa Hakko Kirin
Tuesday, September 19, 13:50-14:40, Annex Hall 2 [Language: Japanese]
Chair: Yoshikazu Ugawa, Japan
Clinical Practice Guideline for Parkinson's Disease in Japan
Kenichi Kashihara, Japan
SESSION 31: WHAT ENDOVASCULAR THERAPY CAN DO FOR ACUTE ISCHEMIC STROKE?
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Stryker Japan K.K.
Tuesday, September 19, 13:50-14:40, Swan Hall [Language: Japanese translated to English]
Chair: Kazunori Toyoda, Japan
Approaches to the Endovascular Therapy for Ischemic Stroke from the Standpoint of Stroke Neurologist
Tatsuo Amano, Japan
Toward the Elimination of Disparities in Endovascular Treatment of Acute Ischemic Stroke
Shinichi Yoshimura, Japan
SESSION 32: STATE OF THE ART; VASCULITIC PERIPHERAL NEUROPATHY
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Teijin Pharma Limited / KAKETSUKEN
Tuesday, September 19, 13:50-14:40, Room B-1 [Language: Japanese translated to English]
Chair: Takashi Kanda, Japan
Intravenous Immunoglobulin (IVIG): Clinical Efficacy and Mechanisms in Systemic Vasculitis as Especially Eosinophilic Granulomatosis with Polyangiitis
Naomi Tsurikisawa, Japan
Diagnosis and Management of Vasculitic Neuropathy
Haruki Koike, Japan
SESSION 33:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Quanterix Corporation / Scrum
Tuesday, September 19, 13:50-14:40, Room B-2 [Language: English]
Chair: Takahiko Tokuda, Japan
New Era of Neurodegenerative Disease Biomarker Research and Diagnosis, Empowered by Single-Molecule Array (Simoa) Technology
Andreas Jeromin, US
SESSION 34: NEW MOVEMENT NEW HORIZON FOR DEVICE AIDED THERAPIES IN JAPAN
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY AbbVie GK
Wednesday, September 20, 12:55-14:40, Annex Hall 2 [Language: English]
Chairs: Satoshi Orimo (Japan), Atsushi Takeda (Japan)
aPD Treatment and 5-2-1 Concept
Angelo Antonini, Italy
Clinical Experience of DAT in Juntendo Univ.
Yasushi Shimo (Japan), Taku Hatano (Japan), Genko Oyama (Japan)
Commentator:
Nobutaka Hattori (Japan), Yoshikazu Ugawa (Japan)
SESSION 35:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Otsuka Pharmaceutica Co., Ltd.
Wednesday, September 20, 12:55-13:45, Room D [Language: Japanese]
Chair: Miho Murata, Japan
Human Neurophysiology and Anti-Parkinson Drugs
Ritsuko Hanajima, Japan
SESSION 36:
Wednesday, September 20, 12:55-13:45, Room E [Language: Japanese translated to English]
Chair: Etsuro Matsubara, Japan
Dementia with Lewy Bodies: An Update
Etsuro Mori, Japan
SESSION 37:
Wednesday, September 20, 12:55-13:45, Swan Hall [Language: English]
Chair: Takeshi Iwatsubo, Japan
Addressing Mechanisms of Neurodegenerative and Neurodevelopmental Disorders
Daniel Curtis, US
SESSION 38:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Astellas Pharma Inc.
Wednesday, September 20, 12:55-13:45, Room B-1 [Language: Japanese translated to English]
Chair: Koichi Hirata, Japan
Treatment Strategy of Restless Legs Syndrome
Yuichi Inoue, Japan
SESSION 39:
Wednesday, September 20, 12:55-13:45, Room B-2 [Language: English]
Chair: Masayasu Matsumoto, Japan
Current Status of Mechanical Thrombectomy and Role of Neurologists for Acute Ischemic Stroke in Japan
Teruyuki Hirano (Japan), Yuji Matsumaru(Japan)
SESSION 40:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nippon Boehringer Ingelheim Co., Ltd.
Wednesday, September 20, 13:50-14:40, Room D [Language: English]
Chair: Mitsutoshi Yamamoto, Japan
Advances of Imaging analysis in Parkinson's Disease
Hirohisa Watanabe, Japan
SESSION 41:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY FUJIFILM RI Pharma Co., Ltd.
Wednesday, September 20, 13:50-14:40, Room E [Language: Japanese]
Chair: Toshiki Mizuno, Japan
Dementia Imaging Diagnosis UPDATE - Role of Cerebral Blood Flow SPECT and Amyloid Imaging
Noriyuki Kimura, Japan
SESSION 42:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Takeda Pharmaceutical Company Limited
Wednesday, September 20, 13:50-14:40, Swan Hall [Language: English]
Chair: Kazuo Fujihara, Japan
Transrational Research Towards Understanding the Pathogenesis of MS/NMO
Takashi Yamamura, Japan
SESSION 43:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Sanofi
Wednesday, September 20, 13:50-14:40, Room B-1 [Language: Japanese translated to English]
Chair: Hidehiro Mizusawa, Japan
Paradigm Shift of Drug Discovery Research for ALS
Gen Sobue, Japan
Essence of Patient Care Not Covered in ALS Guideline
Mieko Ogino, Japan
SESSION 44:
Wednesday, September 20, 13:50-14:40, Room B-2 [Language: English]
Chair: Riki Matsumoto, Japan
AMPA Receptor Disorders
Takuya Takahashi, Japan
SESSION 45:
SYMPOSIUM IS ORGANIZED AND SUPPORTED BY Nihon Kohden
Wednesday, September 20, 13:50-14:40, Room H [Language: English]
Chair: Kohara Nobuo, Japan
Basic Principles and Practice of F‐wave & Blinkreflex
Jun Kimura, US
